Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
View ORCID ProfileMaren Schubert, View ORCID ProfileFederico Bertoglio, View ORCID ProfileStephan Steinke, View ORCID ProfilePhilip Alexander Heine, View ORCID ProfileMario Alberto Ynga-Durand, View ORCID ProfileFanglei Zuo, View ORCID ProfileLikun Du, Janin Korn, Marko Milošević, View ORCID ProfileEsther Veronika Wenzel, Henrike Maass, Fran Krstanović, Saskia Polten, Marina Pribanić-Matešić, Ilija Brizić, Antonio Piralla, View ORCID ProfileFausto Baldanti, Lennart Hammarström, View ORCID ProfileStefan Dübel, Alan Šustić, View ORCID ProfileHarold Marcotte, Monika Strengert, View ORCID ProfileAlen Protić, View ORCID ProfileQiang Pan-Hammarström, View ORCID ProfileLuka Čičin-Šain, View ORCID ProfileMichael Hust
doi: https://doi.org/10.1101/2021.12.10.21267523
Maren Schubert
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Federico Bertoglio
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Stephan Steinke
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Philip Alexander Heine
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Mario Alberto Ynga-Durand
2Helmholtz Centre for Infection Research, Department of Viral Immunology, Inhoffenstr. 7, 38124 Braunschweig, Germany
Fanglei Zuo
3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Likun Du
3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Janin Korn
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
4Abcalis GmbH, Science Campus Braunschweig-Süd, Inhoffenstr. 7, 38124 Braunschweig, Germany
Marko Milošević
5Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Esther Veronika Wenzel
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
4Abcalis GmbH, Science Campus Braunschweig-Süd, Inhoffenstr. 7, 38124 Braunschweig, Germany
Henrike Maass
2Helmholtz Centre for Infection Research, Department of Viral Immunology, Inhoffenstr. 7, 38124 Braunschweig, Germany
Fran Krstanović
6Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Saskia Polten
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Marina Pribanić-Matešić
6Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Ilija Brizić
6Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Antonio Piralla
7Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Fausto Baldanti
7Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy
Lennart Hammarström
3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Stefan Dübel
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Alan Šustić
5Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Harold Marcotte
3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Monika Strengert
9Department of Epidemiology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany
Alen Protić
5Department of Anesthesiology, Reanimation, Intensive Care and Emergency Medicine, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Qiang Pan-Hammarström
3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
Luka Čičin-Šain
2Helmholtz Centre for Infection Research, Department of Viral Immunology, Inhoffenstr. 7, 38124 Braunschweig, Germany
10Centre for Individualised Infection Medicine (CIIM), a joint venture of Helmholtz Centre for Infection Research and Medical School Hannover
Michael Hust
1Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 01, 2022.
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Fanglei Zuo, Likun Du, Janin Korn, Marko Milošević, Esther Veronika Wenzel, Henrike Maass, Fran Krstanović, Saskia Polten, Marina Pribanić-Matešić, Ilija Brizić, Antonio Piralla, Fausto Baldanti, Lennart Hammarström, Stefan Dübel, Alan Šustić, Harold Marcotte, Monika Strengert, Alen Protić, Qiang Pan-Hammarström, Luka Čičin-Šain, Michael Hust
medRxiv 2021.12.10.21267523; doi: https://doi.org/10.1101/2021.12.10.21267523
Human serum from SARS-CoV-2 vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine, Mario Alberto Ynga-Durand, Fanglei Zuo, Likun Du, Janin Korn, Marko Milošević, Esther Veronika Wenzel, Henrike Maass, Fran Krstanović, Saskia Polten, Marina Pribanić-Matešić, Ilija Brizić, Antonio Piralla, Fausto Baldanti, Lennart Hammarström, Stefan Dübel, Alan Šustić, Harold Marcotte, Monika Strengert, Alen Protić, Qiang Pan-Hammarström, Luka Čičin-Šain, Michael Hust
medRxiv 2021.12.10.21267523; doi: https://doi.org/10.1101/2021.12.10.21267523
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)